Inventor · Grez-Doiceau, BE

Jean-Marie Saint-Remy

40Patents
10h-index
10Co-inventors
72Inventor score

Filing activity: Sep 20, 1989 → Jun 30, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US6602509B1 Compound and method for the prevention and/or the treatment of allergy Emerging Cross-Sectional Technologies 23 Expired
US5026545A Treatment of allergy and composition therefor Emerging Cross-Sectional Technologies 17 Expired
US8999346B2 Immunogenic control of tumours and tumour cells Chemistry; Metallurgy 14 Active
US9249202B2 Immunogenic peptides and their use in immune disorders Chemistry; Metallurgy 14 Active
US9248171B2 Immunogenic peptides and their use in transplantation Chemistry; Metallurgy 14 Active
US9394517B2 CD4+ T-cells with cytolytic properties Chemistry; Metallurgy 14 Active
US9861661B2 Elimination of immune responses to viral vectors Chemistry; Metallurgy 13 Active
US9044507B2 Elimination of immune responses to viral vectors Chemistry; Metallurgy 13 Active
US10023847B2 Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination Chemistry; Metallurgy 11 Active
US7067313B1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders Chemistry; Metallurgy 10 Expired
US8277805B2 Methods for treating or inhibiting thromboembolic disorders or for inhibiting coagulation Chemistry; Metallurgy 7 Active
US7785594B2 Factor VIII inhibitory antibodies with reduced glycosylation Chemistry; Metallurgy 6 Active
US7829085B2 Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII Chemistry; Metallurgy 5 Active
US10662232B2 Immunogenic peptides and their use in immune disorders Chemistry; Metallurgy 3 Active
US10808016B2 Peptides and methods for the treatment of diabetes Human Necessities 3 Active
US10617748B2 Immunogenic control of tumours and tumour cells Chemistry; Metallurgy 3 Active
US10982196B2 Immunotherapy targeting intracellular pathogens Chemistry; Metallurgy 2 Active
US11226332B2 Method for the detection, preparation and depletion of CD4+ t lymphocytes Physics 2 Active
US5543145A Pharmaceutical composition and method for the suppression of factor VIII inhibitor production Human Necessities 2 Expired
US11407795B2 Peptides and methods for the treatment of diabetes Human Necessities 2 Active
US11193114B2 Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination Chemistry; Metallurgy 2 Active
US10899795B2 Modified epitopes for boosting CD4+ T-cell responses Chemistry; Metallurgy 2 Active
US10729791B2 Animal models for evaluating pharmaceutical compounds Human Necessities 2 Active
US8282923B2 Antibodies which bind and inhibit blood factor VIII Chemistry; Metallurgy 1 Active
US8293234B2 Antibodies which bind and inhibit blood factor VIII Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.